Jeffrey Ajer

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jeffrey Ajer

Biomarin Pharmaceutical Inc reported in an 8-K filed January 11, 2024 that Jeffrey Ajer was terminated as Executive Vice President and Chief Commercial Officer, effective July 1, 2024.

“Mr. Jeffrey Ajer would step down as the Company's Executive Vice President and Chief Commercial Officer, effective July 1, 2024.”

Biomarin Pharmaceutical Inc Form 8-K, filed January 11, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Jeffrey Ajer's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Biomarin Pharmaceutical Inc (BMRN)
Source not stated

Start not stated–2024-07-01

Company network

Recorded roles and call appearances connecting this person to public companies.

Biomarin Pharmaceutical Inc

BMRN

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Terminated: Executive Vice President and Chief Commercial Officer Biomarin Pharmaceutical Inc (BMRN)
2024-07-01